The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of ARIEL2: A Phase 2 trial to prospectively identify ovarian cancer patients likely to respond to rucaparib using tumor genetic analysis.
 
Iain A. McNeish
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Verastem
Travel, Accommodations, Expenses - Clovis Oncology; Verastem
 
Amit M. Oza
Consulting or Advisory Role - Amgen; Clovis Oncology; Verastem
Research Funding - AstraZeneca; Immunogen; Immunovaccine; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Robert L. Coleman
Honoraria - NCCN
Consulting or Advisory Role - Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche
Research Funding - Amgen; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merrimack; OncoMed
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Gradalis; Merck; Merrimack; Millennium
 
Clare L. Scott
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
Speakers' Bureau - Prime Oncology
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Roche
Other Relationship - Clovis Oncology
 
Gottfried E. Konecny
Consulting or Advisory Role - Novartis
Research Funding - Amgen; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Anna Tinker
Consulting or Advisory Role - AstraZeneca
 
David M. O'Malley
Consulting or Advisory Role - Eisai; Janssen Oncology
Research Funding - Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Immunogen (Inst); Janssen Research & Development (Inst); Regeneron (Inst); VentiRx (Inst)
 
James Brenton
Stock and Other Ownership Interests - Inivata
Consulting or Advisory Role - Inivata
Patents, Royalties, Other Intellectual Property - TAm-Seq v2 method for ctDNA estimation
Travel, Accommodations, Expenses - Aprea AB; Clovis Oncology
 
Rebecca Sophie Kristeleit
Honoraria - Clovis Oncology; Novartis; Roche/Genentech
Consulting or Advisory Role - Clovis Oncology; Novartis
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; PiQuR
 
Katherine Bell-McGuinn
Consulting or Advisory Role - Clovis Oncology
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Roche Pharma AG
 
Alexandra Leary
Honoraria - AstraZeneca; Roche Pharma AG
Research Funding - Array BioPharma (Inst); Clovis Oncology (Inst); Genentech (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - PharmaMar; Roche Pharma AG
 
Kevin Lin
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Mitch Raponi
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Heidi Giordano
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Sandra Goble
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Lindsey Rolfe
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Roman Yelensky
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Andrew R. Allen
Employment - Clovis Oncology
Leadership - Clovis Oncology; Epizyme
Stock and Other Ownership Interests - Clovis Oncology; Epic Sciences; Epizyme
 
Elizabeth M. Swisher
Travel, Accommodations, Expenses - Clovis Oncology